Printer Friendly

Neutrophils in Tissue Trauma of the Skin, Bone, and Lung: Two Sides of the Same Coin.

1. Introduction

The severe inflammatory response after major injury is known to contribute critically to primary healing complications or to induce secondary problems in remote organs, which were not affected initially, including in acute respiratory distress syndrome (ARDS), sepsis, and multiorgan failure (MOF). Neutrophils are part of the "first line of cellular defense" and crucially modulate subsequent repair processes after tissue damage. After injury, neutrophils are rapidly recruited to the inflammation site after injury by microbe- and danger-associated molecular patterns (MAMPs and DAMPs, respectively, with MAMPs also known as PAMPs or pathogen-associated molecular patterns). Multiple inflammatory mediators are potent chemoattractants for neutrophils, including C-X-C motif ligand (CXCL) 1-3, macrophage inflammatory protein-1a, the anaphylatoxin C5a and leukotriene B4 ([LTB.sub.4]), and interleukin-8 (IL-8) [1, 2]. Chemoattractants as IL-8 not only promote chemotaxis but also contribute to a mobilization of immature leukocytes by the bone marrow. This release of immature and, therefore, less deformable neutrophils contributes to a subsequent sequestration in distal organs, laying the foundation to harmful side effects of neutrophils [3]. Following severe trauma or during sepsis, antiapoptotic genes are transiently upregulated, increasing the neutrophil circulation half-time [4]. At the injury site, neutrophils themselves produce a significant amount of [LTB.sub.4] [5], phagocytize cellular debris and bacteria, and subsequently may undergo NETosis, forming neutrophil extracellular traps (NETs). Furthermore, they generate reactive oxygen species (ROS), antimicrobial peptides, serine proteases, and various cytokines and chemotaxins, including interleukin- (IL-) 1[beta], IL-6, IL-10, and monocyte chemotactic protein-1 (MCP-1), which, in turn, modulate the inflammatory response and further attract monocytes and macrophages [6] (for a comprehensive review of neutrophil-derived cytokines, see [7]). It is noteworthy that the quantitative contribution of neutrophils to the overall cytokine concentrations may be relatively low in comparison to macrophages. Nevertheless, the neutrophil response contributes to reduced inflammation and ensures adequate tissue repair [8, 9]. The mechanisms of neutrophil-mediated resolution of inflammation include the clearance of DAMPs and the production of anti-inflammatory cytokines, including IL-10 and IL-1Ra [10], and of lipid mediators [11]. In addition, neutrophils degrade inflammatory cytokines by aggregated NETs, secrete soluble factors, including azurocidin, cathepsin G, lipoxins, and lysophosphatidylserine, and are able to reprogramme macrophages to the regulatory M2 phenotype [6, 12-15].

However, in the case of excessive posttraumatic inflammation, neutrophils may become overactivated or dysfunctional. Consequently, they secrete an altered cytokine profile, increase ROS production, and undergo massive NETosis, thereby aggravating tissue damage and even harming surrounding healthy tissues [15-18]. The majority of studies evaluating neutrophil dysfunctions after trauma address their impaired antimicrobial defense and role in sepsis development [19, 20]. This review focuses on the roles of neutrophils in those organs that are frequently initially affected in traumatized patients: skin, lungs, and bones.

2. Trauma-Induced Phenotype Changes and Functional Consequences

Trauma and subsequent complications affect the phenotype and function of circulating neutrophils, and, particularly, in case of severe trauma, the development of dysfunctional neutrophils might play a detrimental role [21,22]. Indeed, severe posttraumatic inflammation induces a boost in the release of banded and immature neutrophils into the circulation, leading to bone marrow exhaustion and a compromised immune response, both associated with a poor outcome [21, 23, 24]. Additionally, morphological changes were observed after trauma, including increased cell size and membrane plasticity and a modified shape, wherein neutrophils become more elongated [25, 26]. Within the population of neutrophils, there is a degree of heterogeneity that has received growing attention since the 1980s (see [27] for a summary of currently described neutrophil subsets). Until today, there is no certainty to what extent neutrophil heterogeneity is biologically relevant [27, 28]. However, as trauma induces not only an activation of neutrophils, partly accompanied by an extended life span of certain subsets, but also a rapid recruitment of naive cells as well as an emergency granulopoiesis, trauma itself might contribute to neutrophil heterogeneity [29]. For example, in trauma, there are immunosuppressive low-density neutrophils (LDNs), a subtype of neutrophils named after their discovery in the fraction of the peripheral blood mononuclear cells (PMBC) [29, 30]. These granulocytes are not only activated but express a high level of arginase activity, which in turn might be linked to T-cell function providing an interesting modulation and possible impairment of the adaptive immunity mediated by neutrophils during trauma [30]. In sepsis, it has been demonstrated that this granulocyte subset inhibits T-cells, possibly via arginase release and/or ROS production [29, 31, 32]. In contrast, there might be subsets of neutrophils, which are beneficial to repair the initial trauma impact. For example, a population of [CD11b.sup.+]/[Gr1.sup.+]/[CXCR4.sup.hi] neutrophils likely recruited by VEGF-A induce revascularization via MMP-9 [33]. While neutrophil heterogeneity is often described in the context of chronic inflammation, for example, caused by cancer [27, 29], research in the trauma context to elucidate the diametral effects of the neutrophil collectively represents a promising field, which, however, is beyond the scope of this review.

The egress of neutrophils from the bone marrow and their recruitment to the injured tissue is crucial for mounting an adequate inflammatory response. The impairment of targeted chemotaxis has been described in many inflammatory disorders, including diabetes mellitus and viral infections (e.g., HIV and influenza) [34-36]. Adequate chemokinesis is ensured by sufficient expression of surface receptors, including the IL-8 receptors CXCR1 and CXCR2, Fc[gamma]RIII (CD16), IL-6 receptor (IL-6R), and complement receptor C5aR1 [37]. Indeed, trauma is associated with reduced expression of CXCR1, CXCR2, and C5aR1, all of which may be partially internalized by or released from neutrophils in microvesicles [38-40]. IL-6R is actively shed from the neutrophil surface to induce IL-6 transsignaling, which amplifies the inflammatory effects of IL-6 [41], and to regulate T-cell responses [42, 43]. Overall, these trauma-induced functional changes may desensitize neutrophils towards persisting danger.

Killing of phagocyted pathogens in neutrophils is ensured via two distinct mechanisms. One is oxygen based and executed via the formation of ROS, whereas the other is oxygen independent [37]. In trauma, neutrophils produce increased amounts of ROS and increase the expression of gp91PHOX, a membrane-residing subunit of nicotinamide adenine dinucleotide phosphate (NADPH) oxidase, a key enzyme in ROS production [44, 45]. The enhanced ROS response might contribute to the damage of the endothelial barrier and induce vascular leakage, resulting in further complications, including edema and organ dysfunction, for example, ARDS [44, 46]. Oxygen-independent mechanisms include the release of neutrophil granules containing digestive serine proteases, for example, neutrophil elastase, cathepsin G, proteinase 3, and azurocidin [47, 48]. The release of proteases is regulated by the intraphagosomal pH, which, upon improper activation after injury, may lead to impaired protease activation and disturbed microbial killing [49]. Proteases released by neutrophils likely act predominantly locally, as the clearance capacity of antiproteases such as [[alpha].sub.2]-macroglobulin is sufficient to degrade the listed enzymes in a systemic dimension and is increased in scenarios of severe inflammation [50, 51].

Apoptosis and NETosis represent mechanisms of programmed death of neutrophils. Inflammatory stimuli may prolong the circulation half-life of neutrophils from 6 h up to several days based on the upregulation of antiapoptotic proteins, including induced myeloid leukemia cell differentiation protein Mcl-1, and a reduced level of proapoptotic proteins, including apoptosis regulator Bax [11, 52]. However, the functional capacity of such neutrophils remains questionable. NETosis is a mechanism of extracellular neutrophil-mediated killing after cell death. NETs consist of fibrils containing ROS, DNA, chromatin, and granular proteins and are released by active expulsion via an NADPH oxidase-dependent mechanism. Although NETosis is believed to induce programmed cell death, recent data imply that neutrophils may remain viable afterwards [53]. Because NET-mediated destruction is unspecific, excessive NETosis is thought to contribute to tissue damage after trauma [54, 55]. Trauma-induced changes in neutrophil phenotype and functions are summarized in Figure 1.

3. Neutrophil Actions in Specific Trauma Settings

Neutrophil functions may depend on the micromilieu of the damaged tissue. Confirming this, different trauma models frequently produced contradictory results regarding neutrophil functions in different organs. For example, in a model of severe injury, neutrophil depletion did not improve bone regeneration [56], but did mitigate pulmonary damage [17, 57]. Interestingly, a recent study showed that fracture-associated mitochondrial DAMPs may "prime" pulmonary neutrophils, thereby desensitizing them towards pathogens and impairing the pulmonary response to lung infection [58]. These findings could be explained by the compartmentalization of the immune response and by different expression patterns of inflammatory mediators and adhesion molecules in various tissues. Indeed, as already reviewed elsewhere [59], distinct tissues and cell types contribute differently to the production of inflammatory mediators in trauma and sepsis. For example, in sepsis, tumor necrosis factor a (TNFa) is predominantly expressed in the liver, spleen, and lungs by Kupffer cells, leukocytes, and lung epithelial and immune cells, respectively. Additionally, in downstream signaling, for example, in nuclear factor kappa-light-chain-enhancer of activated B cell (NF-[kappa]B) activation, the highest activities were observed in the skin, lungs, and spleen, with minor involvement of the liver, kidney, and heart [60]. Because many inflammatory mediators are important chemotaxins for neutrophil recruitment, it is unsurprising that different organ injuries result in different local and systemic inflammatory patterns. Another possible explanation might be the organ-specific expression of different adhesion molecules, including intercellular adhesion molecule 1 (ICAM-1), vascular cell adhesion protein 1 (VCAM-1), selectins, and CD11b, which are important for the neutrophil influx from the blood vessels into the tissue by mediating their adhesion, rolling, and subsequent migration [59].

In this review, we concentrate on the most frequently injured organs: the skin, as a first target for surface damage; the lungs, which represent a frequent target and major effector organ in trauma, because they are also actively involved in hematopoiesis and coagulation [61]; and the bone, which has a unique micromilieu due to the enclosed bone marrow.

3.1. Role of Neutrophils in Wound Healing. The skin is the first body barrier and is the most frequently injured in trauma. Because skin wounds allow pathogen access to the body, they require an efficient clearing of pathogens and a rapid healing process. Wound healing consists of the interconnected phases of hemostasis and inflammation, tissue regeneration, and remodeling. Hemostasis is initiated within minutes after injury and is accompanied by inflammation and platelet activation, resulting in a stable fibrin clot with an active neutrophil influx [8, 9, 62, 63]. In wounds, neutrophils are recruited by proinflammatory cytokines, including TNFa, growth factors, including platelet-derived growth factor (PDGF) and transforming growth factor [beta] (TGF-[beta]), and arachidonic-acid derivates, including leukotrienes and prostaglandins. Furthermore, neutrophils are attracted by the complement anaphylatoxins C3a and C5a [8, 48, 64, 65]. The physiological role of neutrophils in wound healing does comprise the clearance of not only pathogens but also the abundant erythrocytes [66]. The role of neutrophils in the downstream repair processes remains unclear. On the one hand, neutrophils do not enhance collagen synthesis or granulation tissue formation [67]. Wound healing in germ-free mice, fetuses, and oral mucosa is associated with lower neutrophil-driven inflammation and scarless regeneration, which demonstrates the benefits of a limited neutrophil involvement [64, 68-70]. Additionally, the reduced presence of neutrophils in germ-free lesions correlated with increased levels of the anti-inflammatory cytokine IL-10 and vascular endothelial growth factor (VEGF) and was associated with an accelerated wound epithelialization [68]. On the other hand, in wounds, neutrophils express cytokines, among others TNFa, which can contribute to reepithelialization and wound closure [71, 72]. Furthermore, stimulated neutrophils secrete VEGF, which may contribute to wound healing by encouraging angiogenesis [73]. The process of efficient wound healing also requires neutrophil clearance [48, 74], and it was shown that macrophage stimulation promoted neutrophil removal and wound healing [75]. Indeed, after clearance of MAMPs and DAMPs, neutrophils--via [beta]2 integrins [76]--are phagocyted by macrophages and this is a very strong signal for the macrophage to release TGF-[beta]1. TGF-[beta]1 stimulates differentiation of myofibroblasts, which contribute not only to wound contraction but also to a collagen synthesis [77].

While the presence of neutrophils is generally restricted to the inflammatory phase, it can be prolonged by physical trauma and/or ongoing contamination, thus exerting deleterious effects and inhibiting efficient wound healing [62, 74,78]. DAMPs and MAMPs combined with cytokine release after trauma further extend the inflammatory response of neutrophil in wounds, among others via NF-[kappa]B signaling [79, 80]. The toxic arsenal of neutrophils primarily directed against pathogens leads to collateral damage via distinct mechanisms--particularly, when released as a consequence of necrosis rather than apoptosis. These unwanted side effects damage the extracellular matrix and affect clotting and further mechanisms that are involved in wound healing [48, 62, 81]. The harmful potential of neutrophils is further reflected in the setting of second hits, including in reperfusion injury, which has been demonstrated to increase the invasion of neutrophils, thereby leading to sustained inflammation [82]. Another example of unsolicited effects of neutrophils is excessive NETosis, which has been described as an inhibitor of wound healing in diabetes patients [18]. There are several mechanisms to control neutrophil effects and induce repair. For example, radicals generated by hyperactivated neutrophils are cleared via superoxide dismutase 3 (SOD3) from mesenchymal stem cells (MSCs) [83]. In addition, mesenchymal stem cells can decelerate neutrophil migration via IL-10 and TNF-stimulated gene/protein-6 [84]. Furthermore, epidermal growth factor as part of the saliva lessens neutrophil recruitment and activity, explaining a beneficial effect of wound licking in animals [85].

By contrast, neutrophils also have many positive effects in wound healing. For example, neutrophils counterbalance hyperproliferation, thereby preventing malignancy [64]. From an evolutionary point, the wound-healing mechanism developed when wounds were more likely to be contaminated. Therefore, a pronounced inflammatory response with neutrophils at the wound site neutralizing bacterial intruders might have been crucial to allow for subsequent keratinocyte proliferation [64]. Moreover, neutrophils are required to keep the commensal microbiota in check [68]. Furthermore, delayed healing of infected wounds supplies proliferating skin cells with sufficient oxygen. The oxygen also acts as bactericide and is a prerequisite for neutrophil ROS generation [86]. Additionally, neutrophils support an additional recruitment of macrophages and T-cells by upregulation of MCP-1 and chemokine ligand 3 (CCL3) [4]. The release of carbonic anhydrases by neutrophils alters the wound microenvironment, which supports healing processes under compromised conditions [87].

In summary, neutrophils contribute to the clearing of DAMPs and MAMPs in nonsterile skin lesions, thereby promoting wound healing. However, the presence and activity of neutrophils require tight regulation, which is a challenge, particularly in the setting of severe trauma.

3.2. Role of Neutrophils in Lung Injury. The lung is a unique organ with respect to neutrophil migration, resulting in high neutrophil numbers even in healthy humans. There is growing evidence that under physiological conditions, peripheral-activated neutrophils are cleared and deprimed in a healthy lung [88, 89]. In contrast to other tissues, neutrophils do migrate not only in high endothelial venules via [[beta].sub.2]-integrin but also in the alveolar capillary bed via a L-selectin and [[beta].sub.2]-integrin-independent pathway [90-94]. The capillaries' interwoven network results in a high concentration of neutrophils in the pulmonary vessels compared to blood in the large vessels, which might explain partially the vulnerability of the lung against neutrophil-mediated tissue injury [88, 90, 91, 95]. Another hypothesis emphasizes the role of the lung as a control site for primed neutrophils. If overloaded, the lung might lose its property as site of surveillance and depriming but might even contribute to it [89]. The small diameter of capillary segments (approximately 5 [micro]m) compared with the size of a neutrophil (approximately 78 [micro]m), on the one hand, improves neutrophil contact with the vascular wall, thereby facilitating extravasation, but, on the other hand, requires a high degree of cellular deformability [90, 96]. Neutrophil deformability is modulated by chemotactic factors, including anaphylatoxin C5a [25, 97] and chemotactic tripeptide fMLF (N-formylmethionyl-leucylphenylalanine, previously known as fMLP) [98-100], and by various bacterial compounds, including lipopolysaccharides (LPS) [25, 101]. Transient pulmonary overfishing of neutrophils results in sequestration within the lungs and might contribute to a succeeding reduced cell count in the blood, particularly during the early stage of pulmonary inflammation [97, 101]. Another characteristic of the capillary bed of the lungs are tricellular corners. There, three endothelial cells intersect, building discontinuous tight junctions. Therefore, they provide a possibility to migrate around instead of through endothelial tight junctions, thus contributing to >75% of neutrophil extravasation when stimulated, for example, with IL-1 [102]. In healthy humans, the stimulation of neutrophil pulmonary extravasation by [LTB.sub.4] without further significant inflammatory impact does not cause deterioration in pulmonary barrier permeability, which indicates that physiologically, neutrophils can extravasate without harming the barrier [103]. Accordingly, neutrophils do not require matrix metalloproteinase or serine protease for pulmonary extravasation [104]. In conclusion, in the lungs, neutrophils display unique migration mechanisms, resulting in a large neutrophil number, which is highly relevant in trauma.

ARDS (with mild ARDS being a term for acute lung injury (ALI)) is defined as an "acute diffuse, inflammatory lung injury" caused by primary pulmonary factors (e.g., pneumonia and pulmonary contusion) or secondary harmful events (e.g., polytrauma, shock, burns, and aspiration) [105, 106]. Among trauma patients, mild and severe ARDS occur in 4% and 12%, respectively, and are associated with a longer intensive care unit stay and increased hospital costs [107]. A characteristic ofARDS is severe hypoxemia, which is caused by the leakage of pulmonary vessels with the recruitment of neutrophils, a marked right-to-left shunt and an increased dead space as well as a decrease of pulmonary compliance and a dysfunctional pulmonary epithelium [106]. Although there is numerous data on ARDS and neutrophils [90, 93, 94], the exact role of these cells in ARDS remains poorly understood. In ARDS, inflammatory mediators, including IL-1[beta], IL-6, and IL-8, which are abundantly secreted by type-2 alveolar cells, macrophages, and endothelial cells after blunt chest trauma, induce a hyperactivation of neutrophils [17, 93, 94, 108, 109]. High levels of IL-6 and IL-8 are risk factors for ARDS development after trauma [110, 111]. In traumatic injury, neutrophil activity in general is associated with elevated levels of IL-6, IL-8, and TNF[alpha], but also of IL-10, and, simultaneously, a reduced antimicrobial defense [112-115]. The pulmonary inflammatory mediators further enhance neutrophil activity and their deleterious effect on the endothelium and epithelium. Thereby, they increase transcellular permeability, contributing to lung edema and poor ARDS prognosis [17, 92]. Whereas endothelial cell damage is ROS dependent, epithelial cells might be more resistant towards radicals, but like endothelial cells, they are also affected by activated, adhering neutrophils [116].

Several studies used a neutrophil depletion approach to define the role of neutrophils in trauma. Neutrophil depletion in trauma-induced ARDS was associated with higher chemokine levels in the bronchoalveolar lavage fluid, including granulocyte colony-stimulating factor (G-CSF), and led to an improved outcome [17, 117]. In addition, neutrophil deficiency resulted in reduced IL-1[beta], MIP-2, and TNF[alpha] levels in a mouse hemorrhagic shock model, which underlines the role of neutrophils contributing to pulmonary inflammation [118]. In the absence of neutrophils, some protective effects of the lung-blood barrier were described [17, 119]. Further harmful effects of neutrophils include proteolysis of endo- and epithelial cadherins and attacking the endothelial barrier [120, 121]. In a murine influenza aspiration-induced ARDS model, blockade of neutrophil recruitment via inhibition of the CXCL10-CXCR3 axis resulted in an improved outcome and survival [122]. Furthermore, patients recovering from neutropenia are at risk for ARDS because "reappearing" neutrophils provoke inflammation [123].

However, there are several studies, mainly on infectious- and less in trauma-induced shock, demonstrating that neutrophils are not the only "scapegoat", as pulmonary trauma activates other components of the innate immunity, for example, alveolar macrophages, as well as the coagulation system [124]. For example, neutrophil elastase inhibition did not reduce mortality after ARDS [125]. Another study comparing endotoxin- and bacteria-induced ARDS rat models found that bacteria-triggered ARDS was associated with a poorer outcome, although alveolar neutrophil influx and activity (as determined by elastase or ROS production) were similar. This indicates that there are further factors in addition to neutrophil actions in ARDS development [126]. Furthermore, there is evidence that blunt chest trauma without a second hit induces a transient short-term neutrophil activation with a significant reduction of CXCR2 and C5aR and a mobilization of young (Fc[gamma]RIII-low) neutrophils [127, 128]. Lacking a strong second inflammatory stimulus, for example, subsequent sepsis or pneumonia, inflammation regresses without causing ARDS or MOF, implying a vulnerable phase after trauma-induced immune activation [127, 129, 130].

3.3. Role of Neutrophils in Bone Fracture Healing. Approximately 30% of severely injured patients (injury severity score (ISS) > 16) have concomitant fractures of the extremities [131]. These patients are at a high risk of delayed bone healing or nonunion formation, because of systemic hyperinflammation associated with severe trauma [132-134]. Fractures heal by three partially overlapping phases: the initial inflammatory phase, the repair phase comprising soft callus formation and intramembranous and endochondral ossification, and the remodeling phase, where the initially woven bone is converted to a lamellar bone until the original bone shape is restored [135]. The initial local inflammation starts with rapid hematoma formation, which serves as a scaffold for immune and progenitor cells, initiating regeneration [135]. Neutrophils are the most abundant cells in the early fracture hematoma [136]. Initially, they originate from the blood, leaking from the ruptured vessels. Then they actively migrate from the bloodstream into the damaged bone within minutes after fracture. Moreover, neutrophils or their progenitors can invade the hematoma directly from the damaged bone marrow. Indeed, Hoff et al. reported that, immediately after injury, the fracture hematoma mainly contains bone marrow cells, the majority being [CD16.sup.+]-immature granulocytes [136]. Within 72 h, either maturation of these granulocytes or invasion of [CD16.sup.+]-mature granulocytes from the circulation occurs [136]. Notably, the bone marrow at the fracture site becomes actively involved, because [CD16.sup.+] cells are increasingly found there, indicating general bone-marrow activation in response to injury. The neutrophil numbers rapidly increase at the fracture site during the early inflammatory phase and then slowly subside until day 7-10, when only a few cells are observed in the soft periosteal callus [56, 137, 138].

In uneventful bone healing after isolated fracture, there is a continuing debate over the role of neutrophils [56, 132]. Some authors postulated a negative influence of neutrophils on bone regeneration, because their depletion from the bloodstream improved fracture healing, as confirmed by radiological examination and improved mechanical properties of the healed femur [139]. It was proposed that neutrophils would induce tissue damage by secreting collagenase, elastase, free radicals, and arachidonic acid and that the neutrophil-induced inflammatory response would aggravate the already existing ischemia, leading to edema and a local circulatory shutdown [139]. Others found that neutrophil depletion promoted osteogenic but suppressed chondrogenic differentiation of progenitor cells in a model of growth plate injury; however, the mechanisms were not elucidated [138]. This might be beneficial for intramembranous bone formation, but implies that diaphyseal fracture healing might be delayed, because in this case, cartilaginous callus formation is essential. Interestingly, the authors did not observe any significant influence of neutrophil depletion on the early immune response after fracture, because monocyte and lymphocyte infiltration and IL-1[beta] and TNF[alpha] expression at the injury site were unaffected [138]. Fracture healing was also impaired after zymosan-stimulated ROS production in a rat fracture model [140].

By contrast, stimulation of neutrophil recruitment by G-CSF supported fracture healing. The biomechanical properties of the healed bones were improved [141, 142], bone formation was increased [143], and the expression of angiogenic (angiopoietin, VEGF) and osteogenic (bone morphogenetic proteins--(BMP-) 2 and BMP-4) factors in the fracture callus was enhanced by G-CSF treatment [142]. However, G-CSF does not only promote neutrophil egress into the bloodstream but also facilitate bone marrow stem cell and preosteoblast recruitment to the injury site. Furthermore, it enhances VEGF release and the recruitment of [CD34.sup.+] cells, which contribute to angio- and vasculogenesis [143]. This may improve neovascularization and bone formation independently of enhanced neutrophil recruitment [142, 143].

More recent studies demonstrated that a balanced neutrophil activation may be important for undisturbed fracture healing. After neutrophil depletion with Ly-6G antibody, the recruitment of monocytes and macrophages to the fracture site was disturbed and the concentration of inflammatory mediators, including IL-6, IL-10, CXCL1, and MCP-1, in the fracture hematoma was altered [56, 144]. Subsequent bone regeneration was considerably disturbed in neutrophil-depleted mice. These findings imply that neutrophils crucially regulate the immune response at the fracture site, resolve inflammation, and induce downstream responses, which are essential for successful bone repair. Supporting this, Bastian et al. proposed that neutrophils may form "emergency extracellular matrix" consisting of fibronectin in the initial fracture hematoma, which could serve as a scaffold for stromal cell recruitment, thereby promoting healing [137]. The authors reported that early neutrophil recruitment to the fracture hematoma was associated with fibronectin synthesis. Moreover, neutrophils could be positively costained for fibronectin. Interestingly, the overall cell number in the fracture hematoma was unchanged from days 3 to 10, whereas subpopulation analysis showed that neutrophil numbers diminished, implying that other cell populations, presumably macrophages and stromal cells, invade the fibronectin matrix. At the same time, the fibronectin content was unchanged, whereas the collagen type-1 content increased, indicating that collagen is produced by these newly recruited cells [137]. Therefore, these recent findings support the hypothesis that neutrophils are essential for undisturbed bone regeneration, at least in uneventful bone fracture.

Whether neutrophils play a role in compromised fracture healing associated with severe trauma remains unclear. Several studies found enhanced neutrophil and diminished macrophage recruitment to the fracture hematoma in a rodent model of severe injury, implying that neutrophils might be involved in the pathogenesis of impaired bone healing after trauma [56, 145, 146]. By contrast, bone healing was not improved in a mouse model of combined fracture and thoracic trauma when neutrophils were depleted, suggesting that they may play only a minor role or were dysfunctional in this scenario [56]. The latter suggestion could be confirmed by a recent clinical study of Bastian et al., who reported altered leukocyte kinetics in severely injured patients with subsequent fracture-healing complications [22]. These patients exhibited impaired systemic neutrophil and monocyte mobilization, indicating immune exhaustion.

Even if the current literature is very limited and in part greatly debated, it is clear that neutrophils play a major role in the initial immune response after fracture and initiate downstream responses leading to bone repair. However, further research is necessary to elucidate their role in bone regeneration and the pathogenesis of fracture-healing complications associated with severe trauma.

4. Neutrophils as a Therapeutic Target in Trauma

To utilize the potent defensive mechanisms and clearance capacity for MAMPs and DAMPs by neutrophils in the initial posttraumatic response, enhanced recruitment of neutrophils via G-CSF-based therapeutics, including filgrastim, has been postulated as a rational therapy [147]. Indeed, in the clinical setting of tissue damage after major surgery, GCSF-treatment provoked reinforcement of the systemic innate immune response and reduced septic complications [148]. After acute traumatic brain injury, G-CSF application reduced bacteremia, although overall survival was not improved [149]. However, contradictory effects were reported concerning local healing: In a rodent model of full-thickness supraspinatus tendon defects, G-CSF treatment locally increased cellularity after rotator cuff repair, but failed to improve structural healing [150]. By contrast, accelerated wound healing was found after topical G-CSF application [151]. In a mouse model, the transcriptional coregulator B cell leukemia/lymphoma 3 (Bcl3) was identified to downregulate emergency granulopoiesis as consequence of a transplant-mediated ischemia/reperfusion lung injury, limiting pulmonary damage [152]. In another approach to mitigate neutrophil recruitment, a porcine burn wound model proposed reduced neutrophil activity by the application of atorvastatin [153]. Likewise, attenuation of neutrophil recruitment by neutralization of IL-8 alleviated neutrophil invasion and damage to the lung [154]. Certainly, more research is necessary to define the exact indications after tissue trauma and the dosing, timing, and application route of such approaches.

By contrast, inhibition of extensive neutrophil activation has also been proposed to prevent the collateral damage by neutrophils. For example, in a murine blunt chest injury model with lung contusion, neutrophils and their oxidative response have been identified as a major contributor to acute lung injury and neutrophil depletion was protective [155]. Another experimental study demonstrated the beneficial effect of valproic acid, which reduced neutrophil influx and reduced tissue damage via decreased MPO activity, however with partial immunosuppression [156]. In a mouse model of LPS-induced ARDS, systemic application of mesenchymal stem cells reduced neutrophil recruitment and activity (e.g., NETosis), improving overall survival [157]. Whether the MSCs as cells or parts of their secretome induced these effects remains to be investigated. Leukocyte filtration strategies were also examined in numerous clinical studies, particularly in the context of major cardiac surgery. There is evidence that pulmonary, cerebral, and renal function may improve by neutralization of activated neutrophils using filtration [158, 159]. However, global neutrophil inhibition after severe tissue trauma is certainly irrational and unsafe, because these cells are major contributors of the "first line of defense" to clear the MAMP and DAMP load. Further research needs to determine which specific markers may indicate host-damaging-activated neutrophils. It is also of interest as to which removal strategies should be followed to beneficially modulate the neutrophil immune response after trauma and to induce an effective regenerative process. Future strategies should also account for the different micro-environmental changes after trauma and the compartmentalization of the neutrophil immune response [59]. Therefore, it might be of importance to either enhance or suppress the local neutrophil response, for example, in the fracture hematoma during fracture healing or in the alveolar space after lung contusion. Therefore, organ compartment-targeted neutrophil therapy may represent a promising future scientific and clinical field.

https://doi.org/10.1155/2018/8173983

Conflicts of Interest

The authors declare that there is no conflict of interest regarding the publication of this article.

Authors' Contributions

A. Kovtun and D. A. C. Messerer contributed equally to this work.

Acknowledgments

The authors would like to thank the German Research Foundation for supporting this work in the context of the Collaborative Research Center CRC1149 "Danger Response, Disturbance Factors and Regenerative Potential after Acute Trauma" (to M. Huber-Lang INST 40/479-1, A. Ignatius INST 40/491-1, and K. Scharffetter-Kochanek INST 40/495-1) and the German Federal Ministry of Defence (E/U2AD/CF521/DF555).

References

[1] R. C. Furze and S. M. Rankin, "Neutrophil mobilization and clearance in the bone marrow," Immunology, vol. 125, no. 3, pp. 281-288, 2008.

[2] C. D. Sadik, N. D. Kim, and A. D. Luster, "Neutrophils cascading their way to inflammation," Trends in Immunology, vol. 32, no. 10, pp. 452-460, 2011.

[3] T. Terashima, D. English, J. C. Hogg, and S. F. van Eeden, "Release of polymorphonuclear leukocytes from the bone marrow by interleukin-8," Blood, vol. 92, no. 3, pp. 1062-1069, 1998.

[4] K. Theilgaard-Monch, S. Knudsen, P. Follin, and N. Borregaard, "The transcriptional activation program of human neutrophils in skin lesions supports their important role in wound healing," The Journal of Immunology, vol. 172, no. 12, pp. 7684-7693, 2004.

[5] T. D. Penning, "Inhibitors of leukotriene A4 (LTA4) hydrolase as potential anti-inflammatory agents," Current Pharmaceutical Design, vol. 7, no. 3, pp. 163-179, 2001.

[6] O. Soehnlein, L. Lindbom, and C. Weber, "Mechanisms underlying neutrophil-mediated monocyte recruitment," Blood, vol. 114, no. 21, pp. 4613-4623, 2009.

[7] C. Tecchio, A. Micheletti, and M. A. Cassatella, "Neutrophil-derived cytokines: facts beyond expression," Frontiers in Immunology, vol. 5, 2014.

[8] J. Li, J. Chen, and R. Kirsner, "Pathophysiology of acute wound healing," Clinics in Dermatology, vol. 25, no. 1, pp. 9-18, 2007.

[9] J. E. Park and A. Barbul, "Understanding the role of immune regulation in wound healing," The American Journal of Surgery, vol. 187, no. 5, Supplement 1, pp. S11-S16, 2004.

[10] J. D. Langereis, E.-J. D. Oudijk, R. C. Schweizer, J.-W. J. Lammers, L. Koenderman, and L. H. Ulfman, "Steroids induce a disequilibrium of secreted interleukin-1 receptor antagonist and interleukin-1[beta] synthesis by human neutrophils," European Respiratory Journal, vol. 37, no. 2, pp. 406-415, 2011.

[11] J. Wang and H. Arase, "Regulation of immune responses by neutrophils," Annals of the New York Academy of Sciences, vol. 1319, no. 1, pp. 66-81, 2014.

[12] T. A. Butterfield, T. M. Best, and M. A. Merrick, "The dual roles of neutrophils and macrophages in inflammation: a critical balance between tissue damage and repair," Journal of Athletic Training, vol. 41, no. 4, pp. 457-465, 2006.

[13] Y. Kobayashi, "Neutrophil biology: an update," EXCLI Journal, vol. 14, pp. 220-227, 2015.

[14] S. E. Headland and L. V. Norling, "The resolution of inflammation: principles and challenges," Seminars in Immunology, vol. 27, no. 3, pp. 149-160, 2015.

[15] E. Kolaczkowska and P. Kubes, "Neutrophil recruitment and function in health and inflammation," Nature Reviews Immunology, vol. 13, no. 3, pp. 159-175, 2013.

[16] J. Hazeldine, P. Hampson, and J. M. Lord, "The impact of trauma on neutrophil function," Injury, vol. 45, no. 12, pp. 1824-1833, 2014.

[17] M. Perl, C. Hohmann, S. Denk et al., "Role of activated neutrophils in chest trauma-induced septic acute lung injury," Shock, vol. 38, no. 1, pp. 98-106, 2012.

[18] S. L. Wong, M. Demers, K. Martinod et al., "Diabetes primes neutrophils to undergo NETosis, which impairs wound healing," Nature Medicine, vol. 21, no. 7, pp. 815-819, 2015.

[19] H. Fang, W. Jiang, J. Cheng et al., "Balancing innate immunity and inflammatory state via modulation of neutrophil function: a novel strategy to fight Sepsis," Journal of Immunology Research, vol. 2015, Article ID 187048, 8 pages, 2015.

[20] J. C. Alves-Filho, F. Spiller, and F. Q. Cunha, "Neutrophil paralysis in sepsis," Shock, vol. 34, no. 7, pp. 15-21, 2010.

[21] J. Pillay, B. P. Ramakers, V. M. Kamp et al., "Functional heterogeneity and differential priming of circulating neutrophils in human experimental endotoxemia," Journal of Leukocyte Biology, vol. 88, no. 1, pp. 211-220, 2010.

[22] O. W. Bastian, A. Kuijer, L. Koenderman et al., "Impaired bone healing in multitrauma patients is associated with altered leukocyte kinetics after major trauma," Journal of Inflammation Research, vol. 9, pp. 69-78, 2016.

[23] D. D. Danikas, M. Karakantza, G. L. Theodorou, G. C. Sakellaropoulos, and C. A. Gogos, "Prognostic value of phagocytic activity of neutrophils and monocytes in sepsis. Correlation to CD64 and CD14 antigen expression," Clinical & Experimental Immunology, vol. 154, no. 1, pp. 87-97, 2008.

[24] A. A. Navarini, K. S. Lang, A. Verschoor et al., "Innate immune-induced depletion of bone marrow neutrophils aggravates systemic bacterial infections," Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 17, pp. 7107-7112, 2009.

[25] S. Denk, R. P. Taylor, R. Wiegner et al., "Complement C5ainduced changes in neutrophil morphology during inflammation," Scandinavian Journal of Immunology, vol. 86, no. 3, pp. 143-155, 2017.

[26] S. W. Lam, L. P. H. Leenen, W. W. van Solinge, F. Hietbrink, and A. Huisman, "Comparison between the prognostic value of the white blood cell differential count and morphological parameters of neutrophils and lymphocytes in severely injured patients for 7-day in-hospital mortality," Biomarkers, vol. 17, no. 7, pp. 642-647, 2012.

[27] M. Garley and E. Jablonska, "Heterogeneity among neutrophils," Archivum Immunologiae et Therapiae Experimentalis, vol. 66, no. 1, pp. 21-30, 2018.

[28] J. I. Gallin, "Human neutrophil heterogeneity exists, but is it meaningful?," Blood, vol. 63, no. 5, pp. 977-983, 1984.

[29] P. Scapini, O. Marini, C. Tecchio, and M. A. Cassatella, "Human neutrophils in the saga of cellular heterogeneity: insights and open questions," Immunological Reviews, vol. 273, no. 1, pp. 48-60, 2016.

[30] J. A. Bryk, P. J. Popovic, M. S. Zenati, V. Munera, J. P. Pribis, and J. B. Ochoa, "Nature of myeloid cells expressing arginase 1 in peripheral blood after trauma," The Journal of Trauma, vol. 68, no. 4, pp. 843-852, 2010.

[31] C. J. Darcy, G. Minigo, K. A. Piera et al., "Neutrophils with myeloid derived suppressor function deplete arginine and constrain T cell function in septic shock patients," Critical Care, vol. 18, no. 4, article R163, 2014.

[32] H. Janols, C. Bergenfelz, R. Allaoui et al., "High frequency of myeloid-derived suppressor cells in sepsis patients, with the granulocytic subtype dominating in Gram-positive cases," Critical Care, vol. 18, Supplement 2, 2014.

[33] G. Christoffersson, E. Vagesjo, J. Vandooren et al., "VEGF-A recruits a proangiogenic MMP-9-delivering neutrophil subset that induces angiogenesis in transplanted hypoxic tissue," Blood, vol. 120, no. 23, pp. 4653-4662, 2012.

[34] H. E. Larson, R. P. Parry, and D. A. J. Tyrrell, "Impaired polymorphonuclear leucocyte chemotaxis after influenza virus infection," British Journal of Diseases of the Chest, vol. 74, no. 1, pp. 56-62, 1980.

[35] L. S. Martin, T. J. Spira, S. L. Orloff, and R. C. Holman, "Comparison of methods for assessing chemotaxis of monocytes and polymorphonuclear leukocytes isolated from patients with AIDS or AIDS-related conditions," Journal of Leukocyte Biology, vol. 44, no. 5, pp. 361-366, 1988.

[36] B. Wierusz-Wysocka, H. Wysocki, H. Sieklerka, A. Wykretowicz, A. Szczepanik, and R. Klimas, "Evidence of polymorphonuclear neutrophils (PMN) activation in patients with insulin-dependent diabetes mellitus," Journal of Leukocyte Biology, vol. 42, no. 5, pp. 519-523, 1987.

[37] P. H. C. Leliefeld, C. M. Wessels, L. P. H. Leenen, L. Koenderman, and J. Pillay, "The role of neutrophils in immune dysfunction during severe inflammation," Critical Care, vol. 20, no. 1, p. 73, 2016.

[38] H. Unnewehr, D. Rittirsch, J. V. Sarma et al., "Changes and regulation of the C5a receptor on neutrophils during septic shock in humans," The Journal of Immunology, vol. 190, no. 8, pp. 4215-4225, 2013.

[39] D. E. Van Epps, J. G. Bender, S. J. Simpson, and D. E. Chenoweth, "Relationship of chemotactic receptors for formyl peptide and C5a to CR1, CR3, and Fc receptors on human neutrophils," Journal of Leukocyte Biology, vol. 47, no. 6, pp. 519-527, 1990.

[40] S. K. Raghuwanshi, Y. Su, V. Singh, K. Haynes, A. Richmond, and R. M. Richardson, "The chemokine receptors CXCR1 and CXCR2 couple to distinct G protein-coupled receptor kinases to mediate and regulate leukocyte functions," The Journal of Immunology, vol. 189, no. 6, pp. 2824-2832, 2012.

[41] A. Chalaris, C. Garbers, B. Rabe, S. Rose-John, and J. Scheller, "The soluble interleukin 6 receptor: generation and role in inflammation and cancer," European Journal of Cell Biology, vol. 90, no. 6-7, pp. 484-494, 2011.

[42] J. Pillay, V. M. Kamp, E. van Hoffen et al., "A subset of neutrophils in human systemic inflammation inhibits T cell responses through Mac-1," The Journal of Clinical Investigation, vol. 122, no. 1, pp. 327-336, 2012.

[43] S. Heink, N. Yogev, C. Garbers et al., "Trans-presentation of IL-6 by dendritic cells is required for the priming of pathogenic TH17 cells," Nature Immunology, vol. 18, no. 1, pp. 74-85, 2017.

[44] F. Bao, C. S. Bailey, K. R. Gurr et al., "Increased oxidative activity in human blood neutrophils and monocytes after spinal cord injury," Experimental Neurology, vol. 215, no. 2, pp. 308-316, 2009.

[45] Y. Liao, P. Liu, F. Guo, Z. Y. Zhang, and Z. Zhang, "Oxidative burst of circulating neutrophils following traumatic brain injury in human," PLoS One, vol. 8, no. 7, article e68963, 2013.

[46] E. D. Fox, D. S. Heffernan, W. G. Cioffi, and J. S. Reichner, "Neutrophils from critically ill septic patients mediate profound loss of endothelial barrier integrity," Critical Care, vol. 17, no. 5, article R226, 2013.

[47] N. Borregaard and J. B. Cowland, "Granules of the human neutrophilic polymorphonuclear leukocyte," Blood, vol. 89, no. 10, pp. 3503-3521, 1997.

[48] T. A. Wilgus, S. Roy, and J. C. McDaniel, "Neutrophils and wound repair: positive actions and negative reactions," Advances in Wound Care, vol. 2, no. 7, pp. 379-388, 2013.

[49] R. Bjerknes, H. Vindenes, J. Pitkanen, J. Ninnemann, O. D. Laerum, and F. Abyholm, "Altered polymorphonuclear neutrophilic granulocyte functions in patients with large burns," The Journal of Trauma, vol. 29, no. 6, pp. 847-855, 1989.

[50] A. Banbula, T. P. Zimmerman, and V. V. Novokhatny, "Blood inhibitory capacity toward exogenous plasmin," Blood Coagulation & Fibrinolysis, vol. 18, no. 3, pp. 241-246, 2007.

[51] U. Schaefer, B. Brucker, A. Elbers, and E. Neugebauer, "The capacity of [alpha]2-macroglobulin to inhibit an exogenous protease is significantly increased in critically ill and septic patients," Shock, vol. 22, no. 1, pp. 16-22, 2004.

[52] A. Paunel-Gorgulu, T. Kirichevska, T. Logters, J. Windolf, and S. Flohe, "Molecular mechanisms underlying delayed apoptosis in neutrophils from multiple trauma patients with and without sepsis," Molecular Medicine, vol. 18, pp. 325-335, 2012.

[53] B. G. Yipp, B. Petri, D. Salina et al., "Infection-induced NETosis is a dynamic process involving neutrophil multitasking in vivo," Nature Medicine, vol. 18, no. 9, pp. 1386-1393, 2012.

[54] M. Bosmann and P. A. Ward, "Protein-based therapies for acute lung injury: targeting neutrophil extracellular traps," Expert Opinion on Therapeutic Targets, vol. 18, no. 6, pp. 703-714, 2014.

[55] B. G. Yipp and P. Kubes, "NETosis: how vital is it?," Blood, vol. 122, no. 16, pp. 2784-2794, 2013.

[56] A. Kovtun, S. Bergdolt, R. Wiegner, P. Radermacher, M. Huber-Lang, and A. Ignatius, "The crucial role of neutrophil granulocytes in bone fracture healing," European Cells & Materials, vol. 32, pp. 152-162, 2016.

[57] M. Perl, M. Kieninger, M. S. Huber-Lang et al., "Divergent effects of activated neutrophils on inflammation, Kupffer cell/splenocyte activation, and lung injury following blunt chest trauma," Shock, vol. 37, no. 2, pp. 210-218, 2012.

[58] H. Li, K. Itagaki, N. Sandler et al., "Mitochondrial damage-associated molecular patterns from fractures suppress pulmonary immune responses via formyl peptide receptors 1 and 2," Journal of Trauma and Acute Care Surgery, vol. 78, no. 2, pp. 272-281, 2015.

[59] J. M. Cavaillon and D. Annane, "Compartmentalization of the inflammatory response in sepsis and SIRS," Journal of Endotoxin Research, vol. 12, no. 3, pp. 151-170, 2006.

[60] H. Carlsen, J. 0. Moskaug, S. H. Fromm, and R. Blomhoff, "In vivo imaging of NF-[kappa]B activity," The Journal of Immunology, vol. 168, no. 3, pp. 1441-1446, 2002.

[61] E. Lefrancais, G. Ortiz-Munoz, A. Caudrillier et al., "The lung is a site of platelet biogenesis and a reservoir for haematopoietic progenitors," Nature, vol. 544, no. 7648, pp. 105-109, 2017.

[62] N. X. Landen, D. Li, and M. Stahle, "Transition from inflammation to proliferation: a critical step during wound healing," Cellular and Molecular Life Sciences, vol. 73, no. 20, pp. 3861-3885, 2016.

[63] P. Martin, "Wound healing-aiming for perfect skin regeneration," Science, vol. 276, no. 5309, pp. 75-81, 1997.

[64] J. V. Dovi, A. M. Szpaderska, and L. A. DiPietro, "Neutrophil function in the healing wound: adding insult to injury?," Thrombosis and Haemostasis, vol. 92, no. 2, pp. 275-280, 2004.

[65] H. Sinno and S. Prakash, "Complements and the wound healing cascade: an updated review," Plastic Surgery International, vol. 2013, Article ID 146764, 7 pages, 2013.

[66] D. M. Simpson and R. Ross, "The neutrophilic leukocyte in wound repair a study with antineutrophil serum," The Journal of Clinical Investigation, vol. 51, no. 8, pp. 2009-2023, 1972.

[67] N. Z. Canturk, N. Esen, B. Vural et al., "The relationship between neutrophils and incisional wound healing," Skin Pharmacology and Applied Skin Physiology, vol. 14, no. 2, pp. 108-116, 2001.

[68] M. C. C. Canesso, A. T. Vieira, T. B. R. Castro et al., "Skin wound healing is accelerated and scarless in the absence of commensal microbiota," The Journal of Immunology, vol. 193, no. 10, pp. 5171-5180, 2014.

[69] J. Hopkinson-Woolley, D. Hughes, S. Gordon, and P. Martin, "Macrophage recruitment during limb development and wound healing in the embryonic and foetal mouse," Journal of Cell Science, vol. 107, Part 5, pp. 1159-1167, 1994.

[70] K. W. Liechty, H. B. Kim, N. S. Adzick, and T. M. Crombleholme, "Fetal wound repair results in scar formation in interleukin-10-deficient mice in a syngeneic murine model of scarless fetal wound repair," Journal of Pediatric Surgery, vol. 35, no. 6, pp. 866-873, 2000.

[71] E. Feiken, J. R0mer, J. Eriksen, and L. R. Lund, "Neutrophils express tumor necrosis factor-a during mouse skin wound healing," The Journal of Investigative Dermatology, vol. 105, no. 1, pp. 120-123, 1995.

[72] E. Kanno, K. Kawakami, M. Ritsu et al., "Wound healing in skin promoted by inoculation with Pseudomonas aeruginosa PAO1: the critical role of tumor necrosis factor-a secreted from infiltrating neutrophils," Wound Repair and Regeneration, vol. 19, no. 5, pp. 608-621, 2011.

[73] M. McCourt, J. H. Wang, S. Sookhai, and H. P. Redmond, "Proinflammatory mediators stimulate neutrophil-directed angiogenesis," Archives of Surgery, vol. 134, no. 12, pp. 1325-1331, 1999.

[74] S. de Oliveira, E. E. Rosowski, and A. Huttenlocher, "Neutrophil migration in infection and wound repair: going forward in reverse," Nature Reviews Immunology, vol. 16, no. 6, pp. 378-391, 2016.

[75] Z.-C. Chen, S.-Y. S. Wu, W.-Y. Su et al., "Anti-inflammatory and burn injury wound healing properties of the shell of Haliotis diversicolor," BMC Complementary and Alternative Medicine, vol. 16, no. 1, p. 487, 2016.

[76] T. Peters, A. Sindrilaru, B. Hinz et al., "Wound-healing defect of [CD18.sup.-/-] mice due to a decrease in TGF-[beta]1 and myofibroblast differentiation," The EMBO Journal, vol. 24, no. 19, pp. 3400-3410, 2005.

[77] A. Desmouliere, A. Geinoz, F. Gabbiani, and G. Gabbiani, "Transforming growth factor-[beta]1 induces a-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts," The Journal of Cell Biology, vol. 122, no. 1, pp. 103-111, 1993.

[78] J.-I. Jun, K.-H. Kim, and L. F. Lau, "The matricellular protein CCN1 mediates neutrophil efferocytosis in cutaneous wound healing," Nature Communications, vol. 6, no. 1, article 7386, 2015.

[79] A. O. Aliprantis, R. B. Yang, D. S. Weiss, P. Godowski, and A. Zychlinsky, "The apoptotic signaling pathway activated by Toll-like receptor-2," The EMBO Journal, vol. 19, no. 13, pp. 3325-3336, 2000.

[80] J. G. Kupfner, J. J. Arcaroli, H. K. Yum, S. G. Nadler, K. Y. Yang, and E. Abraham, "Role of NF-[kappa]B in endotoxemiainduced alterations of lung neutrophil apoptosis," Journal of Immunology, vol. 167, no. 12, pp. 7044-7051, 2001.

[81] S. A. Adams, S. L. Kelly, R. E. Kirsch, S. C. Robson, and E. G. Shephard, "Role of neutrophil membrane proteases in fibrin degradation," Blood Coagulation & Fibrinolysis, vol. 6, no. 8, pp. 693-702, 1995.

[82] R. R. Thiagarajan, R. K. Winn, and J. M. Harlan, "The role of leukocyte and endothelial adhesion molecules in ischemiareperfusion injury," Thrombosis and Haemostasis, vol. 78, no. 1, pp. 310-314, 1997.

[83] D. Jiang, J. Muschhammer, Y. Qi et al., "Suppression of neutrophil-mediated tissue damage--a novel skill of mesenchymal stem cells," Stem Cells, vol. 34, no. 9, pp. 2393-2406, 2016.

[84] M. Frieri, K. Kumar, and A. Boutin, "Wounds, burns, trauma, and injury," Wound Medicine, vol. 13, pp. 12-17, 2016.

[85] N. Jahovic, E. Guzel, S. Arbak, and B. Q. Yegen, "The healing-promoting effect of saliva on skin burn is mediated by epidermal growth factor (EGF): role of the neutrophils," Burns, vol. 30, no. 6, pp. 531-538, 2004.

[86] D. B. Allen, J. J. Maguire, M. Mahdavian et al., "Wound hypoxia and acidosis limit neutrophil bacterial killing mechanisms," Archives of Surgery, vol. 132, no. 9, pp. 991-996, 1997.

[87] H. Barker, M. Aaltonen, P. Pan et al., "Role of carbonic anhydrases in skin wound healing," Experimental & Molecular Medicine, vol. 49, no. 5, article e334, 2017.

[88] N. R. P. Singh, A. Johnson, A. M. Peters, J. Babar, E. R. Chilvers, and C. Summers, "Acute lung injury results from failure of neutrophil de-priming: a new hypothesis," European Journal of Clinical Investigation, vol. 42, no. 12, pp. 1342-1349, 2012.

[89] C. Summers, N. R. Singh, J. F. White et al., "Pulmonary retention of primed neutrophils: a novel protective host response, which is impaired in the acute respiratory distress syndrome," Thorax, vol. 69, no. 7, pp. 623-629, 2014.

[90] A. R. Burns, C. W. Smith, and D. C. Walker, "Unique structural features that influence neutrophil emigration into the lung," Physiological Reviews, vol. 83, no. 2, pp. 309-336, 2003.

[91] C. M. Doerschuk, G. P. Downey, D. E. Doherty et al., "Leukocyte and platelet margination within microvasculature of rabbit lungs," Journal of Applied Physiology, vol. 68, no. 5, pp. 1956-1961, 1990.

[92] J. Grommes and O. Soehnlein, "Contribution of neutrophils to acute lung injury," Molecular Medicine, vol. 17, no. 3-4, pp. 293-307, 2011.

[93] J. Reutershan and K. Ley, "Bench-to-bedside review: acute respiratory distress syndrome - how neutrophils migrate into the lung," Critical Care, vol. 8, no. 6, pp. 453-461, 2004.

[94] A. E. Williams and R. C. Chambers, "The mercurial nature of neutrophils: still an enigma in ARDS?," American Journal of Physiology Lung Cellular and Molecular Physiology, vol. 306, no. 3, pp. L217-L230, 2014.

[95] J. C. Hogg, H. O. Coxson, M. L. Brumwell et al., "Erythrocyte and polymorphonuclear cell transit time and concentration in human pulmonary capillaries," Journal of Applied Physiology, vol. 77, no. 4, pp. 1795-1800, 1994.

[96] G. P. Downey and G. S. Worthen, "Neutrophil retention in model capillaries: deformability, geometry, and hydrodynamic forces," Journal of Applied Physiology, vol. 65, no. 4, pp. 1861-1871, 1988.

[97] H. Inano, D. English, and C. M. Doerschuk, "Effect of zymosan-activated plasma on the deformability of rabbit polymorphonuclear leukocytes," Journal of Applied Physiology, vol. 73, no. 4, pp. 1370-1376, 1992.

[98] S. M. Buttrum, E. M. Drost, W. MacNee et al., "Rheological response of neutrophils to different types of stimulation," Journal of Applied Physiology, vol. 77, no. 4, pp. 1801-1810, 1994.

[99] E. M. Drost and W. MacNee, "Potential role of IL-8, platelet-activating factor and TNF-[alpha] in the sequestration of neutrophils in the lung: effects on neutrophil deformability, adhesion receptor expression, and chemotaxis," European Journal of Immunology, vol. 32, no. 2, pp. 393-403, 2002.

[100] G. Worthen, B. Schwab, E. Elson, and G. Downey, "Mechanics of stimulated neutrophils: cell stiffening induces retention in capillaries," Science, vol. 245, no. 4914, pp. 183-186, 1989.

[101] S. C. Erzurum, G. P. Downey, D. E. Doherty, B. Schwab 3rd, E. L. Elson, and G. S. Worthen, "Mechanisms of lipopolysaccharide-induced neutrophil retention. Relative contributions of adhesive and cellular mechanical properties," The Journal of Immunology, vol. 149, no. 1, pp. 154-162, 1992.

[102] D. C. Walker, A. MacKenzie, and S. Hosford, "The structure of the tricellular region of endothelial tight junctions of pulmonary capillaries analyzed by freeze-fracture," Microvascular Research, vol. 48, no. 3, pp. 259-281, 1994.

[103] T. R. Martin, B. P. Pistorese, E. Y. Chi, R. B. Goodman, and M. A. Matthay, "Effects of leukotriene B4 in the human lung. Recruitment of neutrophils into the alveolar spaces without a change in protein permeability," The Journal of Clinical Investigation, vol. 84, no. 5, pp. 1609-1619, 1989.

[104] A. Jill Mackarel, D. C. Cottell, K. J. Russell, M. X. Fitz-Gerald, and C. M. O'Connor, "Migration of neutrophils across human pulmonary endothelial cells is not blocked by matrix metalloproteinase or serine protease inhibitors," American Journal of Respiratory Cell and Molecular Biology, vol. 20, no. 6, pp. 1209-1219, 1999.

[105] C. S. Calfee, M. D. Eisner, L. B. Ware et al., "Trauma-associated lung injury differs clinically and biologically from acute lung injury due to other clinical disorders*," Critical Care Medicine, vol. 35, no. 10, pp. 2243-2250, 2007.

[106] N. D. Ferguson, E. Fan, L. Camporota et al., "The Berlin definition of ARDS: an expanded rationale, justification, and supplementary material," Intensive Care Medicine, vol. 38, no. 10, pp. 1573-1582, 2012.

[107] M. M. Treggiari, L. D. Hudson, D. P. Martin, N. S. Weiss, E. Caldwell, and G. Rubenfeld, "Effect of acute lung injury and acute respiratory distress syndrome on outcome in critically ill trauma patients*," Critical Care Medicine, vol. 32, no. 2, pp. 327-331, 2004.

[108] S. Chollet-Martin, B. Jourdain, C. Gibert, C. Elbim, J. Chastre, and M. A. Gougerot-Pocidalo, "Interactions between neutrophils and cytokines in blood and alveolar spaces during ARDS," American Journal of Respiratory and Critical Care Medicine, vol. 154, no. 3, pp. 594-601, 1996.

[109] M. A. Flierl, M. Perl, D. Rittirsch et al., "The role of C5a in the innate immune response after experimental blunt chest trauma," Shock, vol. 29, no. 1, pp. 25-31, 2008.

[110] R. Pfeifer, J. H. K. Andruszkow, D. Busch et al., "Development of a standardized trauma-related lung injury model," The Journal of Surgical Research, vol. 196, no. 2, pp. 388-394, 2015.

[111] K. Raymondos, M. U. Martin, T. Schmudlach et al., "Early alveolar and systemic mediator release in patients at different risks for ARDS after multiple trauma," Injury, vol. 43, no. 2, pp. 189-195, 2012.

[112] R. K. Bhatia, I. Pallister, C. Dent, S. A. Jones, and N. Topley, "Enhanced neutrophil migratory activity following major blunt trauma," Injury, vol. 36, no. 8, pp. 956-962, 2005.

[113] J. Hazeldine, D. N. Naumann, E. Toman et al., "Prehospital immune responses and development of multiple organ dysfunction syndrome following traumatic injury: a prospective cohort study," PLoS Medicine, vol. 14, no. 7, article e1002338, 2017.

[114] S. A. Jones, "Directing transition from innate to acquired immunity: defining a role for IL-6," The Journal of Immunology, vol. 175, no. 6, pp. 3463-3468, 2005.

[115] G. Zallen, E. E. Moore, J. L. Johnson et al., "Circulating post-injury neutrophils are primed for the release of proinflammatory cytokines," The Journal of Trauma, vol. 46, no. 1, pp. 42-48, 1999.

[116] R. H. Simon, P. D. DeHart, and R. F. Todd 3rd, "Neutrophil-induced injury of rat pulmonary alveolar epithelial cells," The Journal of Clinical Investigation, vol. 78, no. 5, pp. 1375-1386, 1986.

[117] G. Matute-Bello, W. C. Liles, F. Radella II et al., "Modulation of neutrophil apoptosis by granulocyte colonystimulating factor and granulocyte/macrophage colonystimulating factor during the course of acute respiratory distress syndrome," Critical Care Medicine, vol. 28, no. 1, pp. 1 -7, 2000.

[118] E. Abraham, A. Carmody, R. Shenkar, and J. Arcaroli, "Neutrophils as early immunologic effectors in hemorrhage- or endotoxemia-induced acute lung injury," American Journal of Physiology Lung Cellular and Molecular Physiology, vol. 279, no. 6, pp. L1137-L1145, 2000.

[119] T. Narasaraju, E. Yang, R. P. Samy et al., "Excessive neutrophils and neutrophil extracellular traps contribute to acute lung injury of influenza pneumonitis," The American Journal of Pathology, vol. 179, no. 1, pp. 199-210, 2011.

[120] D. Carden, F. Xiao, C. Moak, B. H. Willis, S. Robinson-Jackson, and S. Alexander, "Neutrophil elastase promotes lung microvascular injury and proteolysis of endothelial cadherins," The American Journal of Physiology, vol. 275, 2, Part 2, pp. H385-H392, 1998.

[121] H. H. Ginzberg, V. Cherapanov, Q. Dong et al., "Neutrophil-mediated epithelial injury during transmigration: role of elastase," American Journal of Physiology Gastrointestinal and Liver Physiology, vol. 281, no. 3, pp. G705-G717, 2001.

[122] A. Ichikawa, K. Kuba, M. Morita et al., "CXCL10-CXCR3 enhances the development of neutrophil-mediated fulminant lung injury of viral and nonviral origin," American Journal of Respiratory and Critical Care Medicine, vol. 187, no. 1, pp. 65-77, 2013.

[123] E. Azoulay, M. Darmon, C. Delclaux et al., "Deterioration of previous acute lung injury during neutropenia recovery," Critical Care Medicine, vol. 30, no. 4, pp. 781-786, 2002.

[124] M. Huber-Lang, J. D. Lambris, and P. A. Ward, "Innate immune responses to trauma," Nature Immunology, vol. 19, pp. 327-341, 2018.

[125] K. Iwata, A. Doi, G. Ohji et al., "Effect of neutrophil elastase inhibitor (sivelestat sodium) in the treatment of acute lung injury (ALI) and acute respiratory distress syndrome (ARDS): a systematic review and meta-analysis," Internal Medicine, vol. 49, no. 22, pp. 2423-2432, 2010.

[126] C. Delclaux, S. Rezaiguia-Delclaux, C. Delacourt, C. Brun-Buisson, C. Lafuma, and A. Harf, "Alveolar neutrophils in endotoxin-induced and bacteria-induced acute lung injury in rats," The American Journal of Physiology, vol. 273, 1, Part 1,pp. L104-L112, 1997.

[127] T. Visser, F. Hietbrink, K. M. Groeneveld, L. Koenderman, and L. P. H. Leenen, "Isolated blunt chest injury leads to transient activation of circulating neutrophils," European Journal of Trauma and Emergency Surgery, vol. 37, no. 2, pp. 177-184, 2011.

[128] T. Visser, J. Pillay, P. Pickkers, L. P. H. Leenen, and L. Koenderman, "Homology in systemic neutrophil response induced by human experimental endotoxemia and by trauma," Shock, vol. 37, no. 2, pp. 145-151, 2012.

[129] A. Botha, F. Moore, E. Moore, F. Kim, A. Banerjee, and V. Peterson, "Postinjury neutrophil priming and activation: an early vulnerable window*," Surgery, vol. 118, no. 2, pp. 358-365, 1995.

[130] D. J. McIlroy, A. G. Jarnicki, G. G. Au et al., "Mitochondrial DNA neutrophil extracellular traps are formed after trauma and subsequent surgery," Journal of Critical Care, vol. 29, no. 6, pp. 1133.e1-1133.e5, 2014.

[131] R. Lefering, T. Paffrath, and U. Neunaber, "Trauma register DGU annual report," in German trauma society (DGU), committee on emergency medicine, intensive care and trauma management (Section NIS), and AUC--academy of trauma surgery, 2013.

[132] O. Bastian, J. Pillay, J. Alblas, L. Leenen, L. Koenderman, and T. Blokhuis, "Systemic inflammation and fracture healing," Journal of Leukocyte Biology, vol. 89, no. 5, pp. 669-673, 2011.

[133] A. H. Karladani, H. Granhed, J. Karrholm, and J. Styf, "The influence of fracture etiology and type on fracture healing: a review of 104 consecutive tibial shaft fractures," Archives of Orthopaedic and Trauma Surgery, vol. 121, no. 6, pp. 325-328, 2001.

[134] H. C. Pape, R. Marcucio, C. Humphrey, C. Colnot, M. Knobe, and E. J. Harvey, "Trauma-induced inflammation and fracture healing," Journal of Orthopaedic Trauma, vol. 24, no. 9, pp. 522-525, 2010.

[135] L. Claes, S. Recknagel, and A. Ignatius, "Fracture healing under healthy and inflammatory conditions," Nature Reviews Rheumatology, vol. 8, no. 3, pp. 133-143, 2012.

[136] P. Hoff, T. Gaber, C. Strehl et al., "Immunological characterization of the early human fracture hematoma," Immunologic Research, vol. 64, no. 5-6, pp. 1195-1206, 2016.

[137] O. W. Bastian, L. Koenderman, J. Alblas, L. P. H. Leenen, and T. J. Blokhuis, "Neutrophils contribute to fracture healing by synthesizing fibronectin+ extracellular matrix rapidly after injury," Clinical Immunology, vol. 164, pp. 78-84, 2016.

[138] R. Chung, J. C. Cool, M. A. Scherer, B. K. Foster, and C. J. Xian, "Roles of neutrophil-mediated inflammatory response in the bony repair of injured growth plate cartilage in young rats," Journal of Leukocyte Biology, vol. 80, no. 6, pp. 1272-1280, 2006.

[139] B. Grogaard, B. Gerdin, and O. Reikeras, "The polymorphonuclear leukocyte: has it a role in fracture healing?," Archives of Orthopaedic and Trauma Surgery, vol. 109, no. 5, pp. 268-271, 1990.

[140] E. Gokturk, A. Turgut, C. Baygu, I. Gunal, S. Seber, and Z. Gulbas, "Oxygen-free radicals impair fracture healing in rats," Acta Orthopaedica Scandinavica, vol. 66, no. 5, pp. 473-475, 1995.

[141] M. Bozlar, B. Aslan, A. Kalaci, L. Baktiroglu, A. N. Yanat, and A. Tasci, "Effects of human granulocyte-colony stimulating factor on fracture healing in rats," Saudi Medical Journal, vol. 26, no. 8, pp. 1250-1254, 2005.

[142] T. Fukui, T. Matsumoto, Y. Mifune et al., "Local transplantation of granulocyte colony-stimulating factor-mobilized human peripheral blood mononuclear cells for unhealing bone fractures," Cell Transplantation, vol. 21, no. 4, pp. 707-721, 2012.

[143] K. Ishida, T. Matsumoto, K. Sasaki et al., "Bone regeneration properties of granulocyte colony-stimulating factor via neovascularization and osteogenesis," Tissue Engineering Part A, vol. 16, no. 10, pp. 3271-3284, 2010.

[144] J. K. Chan, G. E. Glass, A. Ersek et al., "Low-dose TNF augments fracture healing in normal and osteoporotic bone by up-regulating the innate immune response," EMBO Molecular Medicine, vol. 7, no. 5, pp. 547-561, 2015.

[145] J. Kemmler, R. Bindl, O. McCook et al., "Exposure to 100% oxygen abolishes the impairment of fracture healing after thoracic trauma," PLoS One, vol. 10, no. 7, article e0131194, 2015.

[146] S. Recknagel, R. Bindl, C. Brochhausen et al., "Systemic inflammation induced by a thoracic trauma alters the cellular composition of the early fracture callus," The Journal of Trauma and Acute Care Surgery, vol. 74, no. 2, pp. 531-537, 2013.

[147] M. Weiss, L. L. Moldawer, and E. M. Schneider, "Granulocyte colony-stimulating factor to prevent the progression of systemic nonresponsiveness in systemic inflammatory response syndrome and sepsis," Blood, vol. 93, no. 2, pp. 425-439, 1999.

[148] C. Schneider, S. von Aulock, S. Zedler, C. Schinkel, T. Hartung, and E. Faist, "Perioperative recombinant human granulocyte colony-stimulating factor (Filgrastim) treatment prevents immunoinflammatory dysfunction associated with major surgery," Annals of Surgery, vol. 239, no. 1, pp. 75-81, 2004.

[149] S. O. Heard, M. P. Fink, R. L. Gamelli et al., "Effect of prophylactic administration of recombinant human granulocyte colony-stimulating factor (filgrastim) on the frequency of nosocomial infections in patients with acute traumatic brain injury or cerebral hemorrhage," Critical Care Medicine, vol. 26, no. 4, pp. 748-754, 1998.

[150] D. Ross, T. Maerz, M. Kurdziel et al., "The effect of granulocyte-colony stimulating factor on rotator cuff healing after injury and repair," Clinical Orthopaedics and Related Research, vol. 473, no. 5, pp. 1655-1664, 2015.

[151] J. Grzybowski, E. Oldak, and M. K. Janiak, "Local application of G-CSF, GM-CSF and EGF in treatment of wounds," Postqpy Higieny i Medycyny Doswiadczalnej, vol. 53, no. 1, pp. 75-86, 1999.

[152] D. Kreisel, S. Sugimoto, J. Tietjens et al., "Bcl3 prevents acute inflammatory lung injury in mice by restraining emergency granulopoiesis," The Journal of Clinical Investigation, vol. 121, no. 1, pp. 265-276, 2011.

[153] J. J. Akershoek, K. M. Brouwer, M. Vlig et al., "Differential effects of losartan and atorvastatin in partial and full thickness burn wounds," PLoS One, vol. 12, no. 6, article e0179350, 2017.

[154] Z. Y. Bao, Q. W. Ye, W. H. Gong, Y. Xiang, and H. Y. Wan, "Humanized monoclonal antibody against the chemokine CXCL-8 (IL-8) effectively prevents acute lung injury," International Immunopharmacology, vol. 10, no. 2, pp. 259-263, 2010.

[155] J. J. Hoth, J. D. Wells, E. M. Hiltbold, C. E. McCall, and B. K. Yoza, "Mechanism of neutrophil recruitment to the lung after pulmonary contusion," Shock, vol. 35, no. 6, pp. 604-609, 2011.

[156] G. Kasotakis, M. Galvan, E. King et al., "Valproic acid mitigates the inflammatory response and prevents acute respiratory distress syndrome in a murine model of Escherichia coli pneumonia at the expense of bacterial clearance," Journal of Trauma and Acute Care Surgery, vol. 82, no. 4, pp. 758-765, 2017.

[157] L. Pedrazza, A. A. Cunha, C. Luft et al., "Mesenchymal stem cells improves survival in LPS-induced acute lung injury acting through inhibition of NETs formation," Journal of Cellular Physiology, vol. 232, no. 12, pp. 3552-3564, 2017.

[158] S. Boodram and E. Evans, "Use of leukocyte-depleting filters during cardiac surgery with cardiopulmonary bypass: a review," The Journal of Extra-Corporeal Technology, vol. 40, no. 1, pp. 27-42, 2008.

[159] G. Matheis, M. Scholz, A. Simon, O. Dzemali, and A. Moritz, "Leukocyte filtration in cardiac surgery: a review," Perfusion, vol. 16, no. 5, pp. 361-370, 2001.

A. Kovtun, (1) D. A. C. Messerer, (2) K. Scharffetter-Kochanek, (3) M. Huber-Lang (ID), (2) and A. Ignatius (ID) (1)

(1) Institute of Orthopedic Research and Biomechanics, Trauma Research Center Ulm, University of Ulm, 89081 Ulm, Germany

(2) Institute of Clinical and Experimental Trauma Immunology (ITI), Trauma Research Center Ulm, University of Ulm, 89081 Ulm, Germany

(3) Department of Dermatology and Allergic Diseases, Trauma Research Center Ulm, University of Ulm, 89081 Ulm, Germany

Correspondence should be addressed to A. Ignatius; anita.ignatius@uni-ulm.de

Received 17 October 2017; Accepted 21 March 2018; Published 23 April 2018

Academic Editor: Benoit Stijlemans

Caption: Figure 1: Trauma-induced changes in neutrophil phenotype lead to neutrophil overactivation and dysfunction, thus negatively affecting migration and maturation, impairing antimicrobial defense and clearance of cell debris, and delaying resolution of inflammation.
COPYRIGHT 2018 Hindawi Limited
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2018 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Author:Kovtun, A.; Messerer, D.A.C.; Scharffetter-Kochanek, K.; Huber-Lang, M.; Ignatius, A.
Publication:Journal of Immunology Research
Date:Jan 1, 2018
Words:10502
Previous Article:Serum and Ectopic Endometrium from Women with Endometriosis Modulate Macrophage M1/M2 Polarization via the Smad2/Smad3 Pathway.
Next Article:Carbamazepine-Mediated Adverse Drug Reactions: CBZ-10,11-epoxide but Not Carbamazepine Induces the Alteration of Peptides Presented by HLA-B*15:02.
Topics:

Terms of use | Privacy policy | Copyright © 2020 Farlex, Inc. | Feedback | For webmasters